Philips' Care Orchestrator to connect Trilogy ventilators to advance care for patients with COPD and other respiratory conditions

AMSTERDAM, July 21, 2016 /PRNewswire/ -- Philips Respironics, a business of Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its Trilogy family of portable ventilators, the most widely used ventilators in North America¹, will be activated to connect to the Care Orchestrator care management application. With complex respiratory illnesses including neuromuscular disorders and COPD on the rise in the U.S., this respiratory care service will enable enhanced care for patients in the home.

Care Orchestrator is a connected health application in the homecare space that connects clinical management workflow, informatics and intelligence for providers, payers and patients within a single cloud-based platform. Once operational later in 2016, Care Orchestrator will interact with Philips' sleep and respiratory devices, electronic medical records (EMRs), insurance claims and billing systems and other Philips and third party applications on the Philips HealthSuite Digital Platform.

"Enabling cloud connectivity of Philips' Trilogy ventilation line is an important step toward our larger ambition to commercialize a respiratory care management service that enables better health and better care at a lower cost," said Eli Diacopoulos, Respiratory Care Business Leader, Philips Respironics. "Philips wants to empower the homecare community to work as one with the patient, enabling increased possibilities in remote patient monitoring and enhanced care from the hospital to the home."

Trilogy ventilators, introduced in 2008, have continued to advance in clinical effectiveness, evolving with features focused on enhancing the patient experience, including therapy algorithms like AVAPs-AE and Mouth Piece Ventilation mode. With a focus on reducing hospitalizations and improving clinical outcomes, Philips has distributed connectivity-ready Trilogy ventilators in North America since 2015 in preparation for the Care Orchestrator launch. Homecare providers will be able to connect thousands of Trilogy ventilators already in market though a simple update once Care Orchestrator is launched later in 2016.

In addition to connecting Trilogy ventilators, Philips will also connect its EverFlo and SimplyGo oxygen concentrators, as well as the iNeb respiratory drug delivery device to Care Orchestrator. With oxygen and respiratory drug delivery devices added to its line of connected solutions, Philips will have the most comprehensive connected respiratory care portfolio² in the homecare industry. 

For more information on innovative respiratory care solutions from Philips, visit http://www.usa.philips.com/healthcare/articles/copd-management-solutions.

For further information, please contact:
Alicia Cafardi
Philips
[email protected] 
412-523-9616

About Philips Respironics
Philips Respironics is a global leader in the sleep and respiratory care markets, offering solutions in sleep apnea management, oxygen therapy, noninvasive ventilation and respiratory drug delivery. With more than 10 years of cloud-based data sharing experience and analytics for more than 7 million patient lives, Philips Respironics has a long history of leading new innovation in both devices and informatics solutions to help patients sleep and breathe better.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Headquartered in the Netherlands, Philips' health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 69,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

¹ A study conducted by AMG Research, an independent third party market research company, with 332 DMEs and 103 Sleep Labs.
² Respiratory care portfolio includes NIV BiPAP, ventilator, oxygen concentrator, nebulizer, metered dose inhaler.

Logo - http://photos.prnewswire.com/prnh/20140122/NE50581LOGO

SOURCE Royal Philips

Related Links

http://www.usa.philips.com